PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients

Por M V Solovev, L P Mendeleeva, M V Firsova, I P Aslanidi, O V Mukhortova, V G Savchenko
Publicado em 2019-07-01

Bone marrow MRI after autologous transplantation and the effect of residual tumor on progression-free survival of multiple myeloma patients

Por M. V. Solovev, L. P. Mendeleeva, G. A. Yatsyk, N. S. Lutsik, M. V. Firsova, E. G. Gemdzhian, V. G. Savchenko
Publicado em 2019-01-01

STUDY OF MINIMAL RESIDUAL DISEASE BY MULTICOLOR FLOW CYTOMETRY IN MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

Por I. V. Galtseva, L. P. Mendeleeva, Y. O. Davydova, M. V. Solov’ev, N. M. Kapranov, L. A. Kuzmina, E. O. Gribanova, T. V. Gaponova, V. G. Savchenko
Publicado em 2017-06-01